CenExel Clinical Research recently strengthened its psychiatric team with the recruitment of Mark N. Lerman, MD, to serve as a principal investigator for phase I-IV studies at the Atlanta Center for Medical Research (ACMR), a CenExel Center of Excellence.
Genomic Testing Cooperative, LCA announced that the Medicare Administrative Contractor Palmetto GBA (MolDx®) has established coverage for its solid tumor molecular profile.
GB Sciences, Inc. (OTCQB: GBLX) announced significant preclinical results for their Parkinson's disease ("PD") formulations from the midterm report for their preclinical study being performed by Dr. Lee Ellis of the National Research Council (NRC) in Halifax, Nova Scotia, CANADA.
Hememics Biotechnologies Inc., ("Hememics" or the "Company") announced that AMVI Partners, a consortium of high net worth Vietnamese investors, has invested $2.5 million into Hememics. The company will use the funds to initiate clinical research for supporting a U.S. Food and Drug Administration (FDA) submission of a novel point-of-care technology for detection of pathogens in under a minute.
GO2 Foundation for Lung Cancer announced the recipients of the 2019 Young Innovators Team Awards (YITA) today. Two teams of researchers received grants totaling $500,000 for their work developing novel strategies to treat KRAS-mutant non-small cell lung cancer (NSCLC) and examining the impact of age on development, progression, and immunotherapy response in NSCLC.
Healthy Humming, LLC is pleased to announce positive topline data from a prospective outcomes study, which assessed the safety and efficacy of the SinuSonic, a nasal congestion treatment device that combines nasal acoustic vibration with oscillating expiratory pressure.
Buffalo-based clinical-stage biotechnology company MimiVax, a Roswell Park Comprehensive Cancer Center spinoff, set to work with leading healthcare group in China to provide promising immunotherapy
The U.S. Food and Drug Administration (FDA) has awarded AnaBios an exclusive Indefinite Delivery Indefinite Quantity (IDIQ) contract to employ adult human primary tissues and cardiomyocytes from organ donors to assess drug safety related to cardiac function.
MeriCal, the largest supplier of store brand probiotics, announced today that it has completed and launched the first USP Verified probiotic supplement.
The Rockefeller University has announced that Xiaowei Zhuang, inventor of novel molecular-imaging techniques, will be awarded the 2019 Pearl Meister Greengard Prize, the preeminent international award for women in biomedical science. Zhuang is the David B. Arnold Professor of Science at Harvard University, and a Howard Hughes Medical Institute investigator. She will receive the prize on November 19 at a ceremony at Rockefeller hosted by the architect Billie Tsien.
The American Academy of Orthopaedic Manual Physical Therapists (AAOMPT) has released a position statement opposing "degenerative disc disease" as a diagnostic term for the cause of neck and back pain. AAOMPT publicly announced its position during the organization's annual conference in Orlando, Florida, on Oct. 25.
To conduct preclinical testing of locally-acting topical dermal and ophthalmic drug product formulations
The need to feel balanced drives the development of coordination between body and limbs as zebrafish larvae learn to swim, a new study by NYU School of Medicine finds.
Dr. Jeffrey Cummings, a world-renowned Alzheimer's researcher and leader in clinical trials, has been named the recipient of the 2019 Melvin R. Goodes Prize for Excellence in Alzheimer's Drug Discovery. The prize, awarded by the Alzheimer's Drug Discovery Foundation (ADDF), recognizes leading researchers developing treatments for Alzheimer's disease and related dementias.
The U.S. Food and Drug Administration (FDA) has named AnaBios the recipient of a grant to further develop its unique drug discovery platform utilizing muscle cells from the human heart (cardiomyocytes).
Hollins Communications Research Institute (HCRI), a national center for stuttering research and therapy innovation, just completed another research initiative in collaboration with the National Institutes of Health (NIH). The study is the first to evaluate stuttering therapy outcomes among a group of stutterers who possess one of four mutant genes for stuttering in comparison to a group who do not carry the same mutant genes.
Ablacon, Inc. (www.ablacon.com), an Ajax Health-funded company, announced today the release of an updated version of its Ablamap technology under the company's existing CE Mark.
JOGOHEALTH Inc., a privately held digital therapeutics company focused on the development and commercialization of treatments for neuromuscular (NM) conditions such as stroke, spinal cord injury, cerebral palsy and urinary incontinence today announced that it will present evidence and performance of its lead investigational product JOGO, at the 2019 Australian & New Zealand Spinal Cord Society (ANZSCoS) Annual Scientific Meeting held at Pullman Melbourne Albert Park in Melbourne, Australia from 21 - 23 August 2019.
Physical Optics Corporation (POC) is pleased to announce an SBIR Phase III award of over $4M for the production investigation of optical fibers in zero-gravity.
AnaBios Corp. today announced it is providing validated human dorsal root ganglion (hDRG) to the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), for research collaborations to develop human cell-based screening platforms and novel drugs to treat pain and opioid use disorder.
The 20th International Conference on Alzheimer's Drug Discovery, a two-day interdisciplinary forum to be held September 16-17, 2019 in Jersey City, NJ
Researchers can identify therapeutic targets and functional effects of targeted therapeutics more quickly and efficiently as part of a complete solution now offered by LI-COR Biosciences in partnership with NMI TT Pharmaservices.
Scientific knowledge can now be produced and managed in a single Life Sciences R&D Cloud.
Burst Biologics, a globally recognized institute in pharmaceutical research and tissue bank that services communities across the U.S., has published a research study entitled "Characterization of an umbilical cord blood sourced product suitable for allogeneic applications" in the prestigious peer-reviewed journal, Regenerative Medicine. This study is part of Burst Biologics' ongoing commitment to groundbreaking research.
The Chicago Quantum Exchange, a growing intellectual hub for the research and development of quantum technology, has expanded its community to include new industry partners working at the forefront of quantum technology and research. These corporate partners are Boeing, Applied Materials, Inc., ColdQuanta, Inc., HRL Laboratories LLC and Quantum Opus LLC.
SOFIE Inc. (SOFIE), a Theranostics company, is pleased to announce an exclusive global license with University Clinic Heidelberg (UKHD) for a class of molecular targeted diagnostics
Dr. Jamie Perry has been named the editor of The Cleft Palate-Craniofacial Journal (CPCJ), a peer-reviewed publication dedicated to prevention, diagnosis and interdisciplinary treatment of cleft and cleft palate and other craniofacial conditions.
Intrexon Corporation (Intrexon) (NASDAQ: XON), a leader in the engineering and industrialization of biology to improve quality of life and health of the planet
The costs and timelines to conduct clinical trials continue to increase, along with study complexity. While much of the focus within clinical trials has been on improving data integrity and overall study efficiency, addressing costs, timeline and complexity issues, one must analyze the impact of having all these components come together for a trial's success. ClinOne does just that by addressing and refining them with its multi-module platform.
Inari Medical, Inc. announced today the publication of its 106-patient prospective multicenter FlowTriever Mechanical Pulmonary Embolectomy (FLARE) study for the treatment of intermediate-risk pulmonary embolism (PE). The study was published in JACC: Cardiovascular Interventions.
Ablacon, Inc. (www.ablacon.com), a Wheat Ridge, CO-based company developing an advanced mapping system to guide the treatment of atrial fibrillation (AFib)
ESAOTE, one of the world's leading manufacturers of diagnostic ultrasound systems and probes
In Physical Optics Corporation's (POC) first endeavor into the space domain, an engineering prototype designed and built by our Applied Technologies Division rockets into orbit to meet the International Space Station (ISS). This NASA-sponsored advanced materials research study is intended to evaluate the feasibility of producing high-quality increased bandwidth optical fibers in zero-gravity.
Collaborative Medicinal Development LLC (CMD), announces that it was awarded a AU$1 million grant
As part of its Diagnostics Accelerator research program, the Alzheimer's Drug Discovery Foundation (ADDF) announced today a new initiative that aims to fast-track the development of digital tools for Alzheimer's disease and related dementias.
Sapio Sciences is pleased to announce the availability of Exemplar LIMS/ELN 11, a major expansion of our leading informatics platforms capabilities. Exemplar 11 focuses strongly on our drive to continuously improve user experience via interface enhancements. This release includes new data navigation aids, expanded searching capability, easier data viewing setup and new data and activity viewing components to enable quick and easy finding, viewing and traversing of your lab and scientific data.
Shield Diagnostics, an Andreessen Horowitz-backed clinical laboratory tackling antibiotic resistance by bringing precision medicine to infectious disease, announced the launch of Target-NG, a rapid molecular test for antibiotic susceptibility in Neisseria gonorrhoeae.
Cognitive impairment affects more than 50 million people worldwide. In the United States alone, one in three seniors dies with some type of dementia. This creates a critical clinical need for safe and effective therapies for the treatment and prevention of cognitive impairment.
Synthego, a leading genome engineering innovation company, today announced its inaugural Genome Engineer Innovation Grant. As part of the company's mission to make world-class genome engineering tools accessible to all scientists and bring first-of-its-kind research to fruition, Synthego will offer a variety of grants to research lab awardees totaling $1 million worth of CRISPR Engineered Cells and CRISPRevolution synthetic sgRNA kits.
Cayuse, a leader in research administration software for universities, hospitals, and research organizations today announced the expansion of its Partnership ecosystem with the addition of InfoReady Corporation.
Neuspera Medical Inc., a clinical stage, private venture capital backed neuromodulation company, today announced the final closing (2nd tranche) of the company's Series B equity financing.
Flowonix Medical, Inc. today announced United States Food and Drug Administration (FDA) approval to market the Flowonix Maestro™ Software for Clinician Programmers used to program Prometra® Pump Systems.
The Alzheimer's Drug Discovery Foundation's (ADDF) Diagnostics Accelerator initiative has announced a new $5 million commitment to projects targeting the development of biomarkers for frontotemporal degeneration (FTD), the most common dementia for people under 60.
A scientific strategy that explores therapeutic targets based on the biology of aging is gaining ground as an effective approach to prevent and treat Alzheimer's disease, according to research published in the December 7, 2018 online issue of Neurology®.
Perosphere Pharmaceuticals Inc. today announced the presentation of clinical study results demonstrating, "Ciraparantag Safely and Effectively Reverses Apixaban and Rivaroxaban in Age-matched Healthy Volunteers as Measured by Whole Blood Clotting Time," at the American Society of Hematology (ASH) annual meeting in San Diego on Monday, December 3, 2018.
Support for oncology nursing is critical to the advancement of the profession and the future of care for patients with cancer. The Oncology Nursing Foundation—formerly known as the Oncology Nursing Society (ONS) Foundation—is a nonprofit, tax-exempt, charitable organization dedicated solely to supporting oncology nurses both nationally and internationally.
TCS Healthcare Technologies is excited to announce the launch of ACUITYnxt, the latest generation of software products to support the care management industry.
At-home blood sampling streamlines the process of therapeutic drug monitoring and creates comfort and emotional safety for children
Progentec Diagnostics, Inc. ("Progentec"), a leader in the development of technological innovations in the field of diagnostics, today announced the completion of a second round of funding co-led by i2E and Chicago-based OCA Ventures.
The Alzheimer's Drug Discovery Foundation (ADDF) is saddened to hear the news that former Supreme Court Justice Sandra Day O'Connor released a letter today saying she has been diagnosed with the beginning stages of dementia, probably Alzheimer's disease.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right